Weiss Multi-Strategy Advisers’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-75,569
| Closed | -$2.12M | – | 836 |
|
|
2022
Q1 | $2.12M | Hold |
75,569
| – | – | 0.05% | 398 |
|
|
2021
Q4 | $2.06M | Sell |
75,569
-832
| -1% | -$22.5K | 0.05% | 383 |
|
|
2021
Q3 | $2.08M | Buy |
76,401
+36,227
| +90% | +$896K | 0.04% | 404 |
|
|
2021
Q2 | $687K | Buy |
40,174
+1,439
| +4% | +$26.9K | 0.02% | 531 |
|
|
2021
Q1 | $809K | Sell |
38,735
-471
| -1% | -$10.9K | 0.02% | 510 |
|
|
2020
Q4 | $898K | Sell |
39,206
-1,244
| -3% | -$23.7K | 0.02% | 501 |
|
|
2020
Q3 | $660K | Sell |
40,450
-4,654
| -10% | -$84.3K | 0.02% | 455 |
|
|
2020
Q2 | $611K | Sell |
45,104
-3,141
| -7% | -$36.5K | 0.02% | 453 |
|
|
2020
Q1 | $572K | Buy |
48,245
+18,245
| +61% | +$405K | 0.02% | 337 |
|
|
2019
Q4 | $747K | Buy |
30,000
+5,000
| +20% | +$101K | 0.01% | 512 |
|
|
2019
Q3 | $425K | Buy |
+25,000
| New | +$455K | 0.01% | 504 |
|
|
2019
Q2 | – | Sell |
-10,000
| Closed | -$270K | – | 672 |
|
|
2019
Q1 | $322K | Hold |
10,000
| – | – | 0.01% | 459 |
|
|
2018
Q4 | $282K | Buy |
+10,000
| New | +$293K | 0.01% | 390 |
|
|
2018
Q3 | – | Sell |
-17,500
| Closed | -$655K | – | 698 |
|
|
2018
Q2 | $655K | Buy |
17,500
+7,500
| +75% | +$294K | 0.02% | 473 |
|
|
2018
Q1 | $393K | Buy |
+10,000
| New | +$365K | 0.01% | 475 |
|
Weiss Multi-Strategy Advisers's XENT Position: Q2 2022 in Review
Weiss Multi-Strategy Advisers sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 75,569 shares — an estimated $2.12M sold.
Weiss Multi-Strategy Advisers first reported a position in XENT in Q1 2018 and held it in 15 quarters. The position peaked at $2.12M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Weiss Multi-Strategy Advisers reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Weiss Multi-Strategy Advisers sold 75,569 Intersect ENT, Inc shares in Q2 2022, an estimated $2.12M.
- Weiss Multi-Strategy Advisers first reported a position in Intersect ENT, Inc in Q1 2018 and held it in 15 quarters.
- Weiss Multi-Strategy Advisers's Intersect ENT, Inc position peaked at $2.12M in Q1 2022.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.